ANDA 90176, held by Bionpharma. Azelastine Hydrochloride.
As of Nov 16, 2026, ANDA 90176 (Azelastine Hydrochloride), held by Bionpharma, was first approved by FDA on Jul 28, 2015, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 28, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Azelastine Hydrochloride0.137MG/SPRAY · spray, metered;nasal | Azelastine Hydrochloride | Discontinued |
| Apr 30, 2021 | Supplement 7Labeling · Standard review | Approved | None posted |
| Apr 30, 2021 | Supplement 4Labeling · Standard review | Approved | None posted |
| Nov 6, 2017 | Supplement 1Manufacturing | Approved | None posted |
| Jul 28, 2015 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters